
Who is Dr. Benitz, Neonatal-Perinatal Medicine Specialist in Palo Alto, CA?
Dr. William Benitz, MD is a Neonatal-Perinatal Medicine Specialist, who primarily practices in Palo Alto, CA. He is board certified. Dr. Benitz completed his residency at Stanford Univ Hosp, Neonatal-Perinatal Medicine; Stanford Univ Hosp, Pediatrics. Dr. Benitz is fluent in English and Spanish, and is currently seeing new patients. Dr. Benitz’s practice accepts Aetna, Cigna and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Benitz’s office at (650) 497-8000.
What are Areas of Expertise for Dr. Benitz?
Dr. William Benitz, MD is a highly-rated, board-certified Neonatal-Perinatal Medicine Specialist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Benitz empowers patients to confidently navigate their health journey, specializing in Infections-Neonatal, Lung Disease in Newborns, and comprehensive wellness support. Serving the Palo Alto, CA community, Dr. Benitz is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Benitz go to medical school and complete their residency?
Fellowship: Stanford University School of Medicine, Stanford, CA | Stanford University School of Medicine CA
Residency: Stanford Univ Hosp, Neonatal-Perinatal Medicine; Stanford Univ Hosp, Pediatrics | Stanford University Medical Center
Medical School: Stanford Univ Sch Of Med- Stanford Ca
Is Dr. Benitz board certified as a Neonatal-Perinatal Medicine Specialist?
Yes, Dr. William Benitz, MD is board certified by the American Board of Pediatrics , American Board of Pediatrics since 1985, American Board of Pediatrics since 1983
What languages does Dr. Benitz speak?
Dr. Benitz and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does a Neonatal-Perinatal Medicine Specialist like Dr. Benitz typically treat?
As a Neonatal-Perinatal Medicine Specialist, conditions treated by Dr. William Benitz may include:
- Cri du Chat
- Down Syndrome
- Fifth Disease
- Tay Sachs Disease
- Triple X Syndrome
- Turner Syndrome
- VRE
- Whooping Cough
Please contact Dr. Benitz's office directly to confirm care for your specific condition, for more information, or to schedule a consultation.
What procedures does a Neonatal-Perinatal Medicine Specialist like Dr. Benitz typically perform?
As a Neonatal-Perinatal Medicine Specialist, procedures performed by Dr. William Benitz may include:
- 12 Month Well-Baby Checkup
- 15 Month Well-Baby Checkup
- 18 Month Well-Baby Checkup
- 1 Month Well-Baby Checkup
- 24 Month Well-Baby Checkup
- 2 Month Well-Baby Checkup
- 2 Week Well Baby Checkup
- 30 Month Well-Baby Checkup
Please contact Dr. Benitz's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Benitz accept my insurance?
Dr. Benitz accepts most major insurance plans. Important: Please call our office at (650) 497-8000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Benitz accept in Palo Alto, CA?
Dr. Benitz in Palo Alto, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Aetna
Blue Cross Blue Shield
Blue Cross Blue Shield of Illinois
Blue Cross Blue Shield of Michigan
Capital Blue Cross
Cigna
Elevance Health Inc. (formerly Anthem)
Empire Blue Cross Blue Shield
Harvard Pilgrim
Oscar
View All Insurances
Where is Dr. Benitz's office located?
Recognitions
Publications
Anti-Ge3 causes late-onset hemolytic disease of the newborn
, 2013
Prevention of Postpartum Traumatic Stress in Mothers with Preterm Infants
, 2013
Patent ductus arteriosus: to treat or not to treat?
, 2012
Neotal Informatics: Transforming Neotal Care Through Translatiol Bioinformatics.
, 2012
Learning to live with patency of the ductus arteriosus in preterm infants
, 2011
Adjunct Laboratory Tests in the Diagnosis of Early-Onset Neotal Sepsis
, 2010
Treatment of persistent patent ductus arteriosus in preterm infants
, 2010
Daily Compared With 8-Hour Gentamicin for the Treatment of Intrapartum Chorioamnionitis A R
, 2010
Combining hand techniques with electric pumping increases milk production in mothers of preterm
, 2009
Use of caffeine for apnea of prematurity also has long-term neurodevelopmental benefits
, 2008
Once daily vs. 8-hour gentamicin dosing for chorioamnionitis
, 2007
The use of inhaled nitric oxide in the premature infant with respiratory distress syndrome.
, 2006
Criteria supporting the study of drugs in the newborn
, 2006
Comparison of rapid intrapartum screening methods for group B streptococcal vagil colonization
, 2005
Food, toys, and love: pediatric palliative care.
, 2005
Utilization and outcomes of neotal cardiac extracorporeal life support: 1996-2000.
, 2005
Reduction in red blood cell transfusions using a bedside alyzer in extremely low birth weight
, 2005
Reduction in red blood cell transfusions using a bedside alyzer in extremely low birth weight
, 2004
Retinopathy of prematurity and pulse oximetry: a tiol survey of recent practices.
, 2004
Readmission for newborn jaundice
, 2004
Maintaining adequate anticoagulation on extracorporeal membrane oxygetion therapy
, 2003
Perital screening for group B streptococci: Cost-benefit alysis of rapid polymerase chain reaction
, 2002
Perital treatment to prevent early onset group B streptococcal sepsis.
, 2002
Effect of an evidence-based hand washing policy on hand washing rates and false
, 2002
Venoarterial versus venovenous extracorporeal membrane oxygetion in congenital diaphragmatic hernia
, 2001
Secondary infection presenting as recurrent pulmory hypertension.
, 2000
Mortality and time to death in very low birth weight infants: California, 1987 and 1993
, 2000
Alveolar capillary dysplasia: diagnostic potential for cardiac catheterization.
, 1999
Risk factors for early-onset group B streptococcal sepsis
, 1999
Preventing early-onset group B streptococcal sepsis: Strategy development using decision alysis
, 1999
Antimicrobial prevention of early-onset group B streptococcal sepsis
, 1999
Serial serum C-reactive protein levels in the diagnosis of neotal infection
, 1998
Neutrophil CD11b expression as a diagnostic marker for early-onset neotal infection
, 1998
Serial measurements of serum C-reactive protein in the diagnosis of neotal infection
, 1997
Hemopericardium from corory artery laceration complicating extracorporeal membrane oxygetion.
, 1997
Neotal severity of illness scoring systems: A comparison
, 1997
Sedation administered to very low birth weight premature infants.
, 1997
Plasma concentrations after rectal administration of acetaminophen in preterm neotes
, 1997
Nitrovasodilator therapy for severe respiratory distress syndrome.
, 1996
INDIVIDUALIZED DEVELOPMENTAL CARE FOR VERY-LOW-BIRTH-WEIGHT PREMATURE-INFANTS
, 1995
LOBAR LUNG TRANSPLANTATION AS A TREATMENT FOR CONGENITAL DIAPHRAGMATIC-HERNIA
, 1994
INTRACRANIAL ABNORMALITIES AND NEURODEVELOPMENTAL STATUS AFTER VENOVENOUS EXTRACORPOREAL MEMBRANE
, 1994
MAXIMIZING THE STABILITY OF OXYGEN DELIVERED VIA SAL CANNULA
, 1994
A paradigm for making difficult choices in the intensive care nursery.
, 1993
NONINVASIVE METHODS FOR ESTIMATING INVIVO OXYGETION
, 1992
ENDOTHELIAL-CELL PROTEOGLYCANS - POSSIBLE MEDIATORS OF VASCULAR-RESPONSES TO INJURY
, 1990
THE USE OF ANTIBIOTICS IN NEOTES WEIGHING LESS THAN 1200 GRAMS
, 1990
ENDOTHELIAL HEPARAN-SULFATE PROTEOGLYCAN .1. INHIBITORY EFFECTS ON SMOOTH-MUSCLE CELL-PROLIFERATION
, 1990
PRODUCTION OF BASEMENT-MEMBRANE HEPARAN
, 1989
PRESENCE OF INSULINLIKE GROWTH-FACTOR RECEPTORS AND LACK OF INSULIN
, 1988
ENDOTOXIN AND PULMORY CELL INJURY
, 1988
Outcome of neotes with birth weights of less than 801 grams.
, 1988
ENDOTOXIN MEDIATED ENDOTHELIAL INJURY - EFFECT OF ALTERED CALCIUM HOMEOSTASIS
, 1988
REFRACTORY NEOTAL HYPOXEMIA - DIAGNOSTIC EVALUATION AND PHARMACOLOGIC MAGEMENT
, 1988
CORRELATION OF ECHOENCEPHALOGRAPHIC FINDINGS AND NEURODEVELOPMENTAL OUTCOME
, 1987
A PRACTICAL APPROACH TO DIAGNOSIS AND IMMEDIATE CARE OF THE CYANOTIC NEOTE
, 1987
Immediate magement of the asphyxiated infant
, 1987
MEDICATION ERROR PREVENTION BY CLINICAL PHARMACISTS IN 2 CHILDRENS HOSPITALS
, 1987
ENDOTOXIN EFFECTS ON CELL-PERMEABILITY
, 1987
HYPOXIA INHIBITS PROLIFERATION OF FETAL PULMORY ARTERIAL SMOOTH-MUSCLE CELLS-INVITRO
, 1986
THE PHARMACOLOGY OF NEOTAL RESUSCITATION AND CARDIOPULMORY INTENSIVE-CARE .2. EXTENDED INTENSIVE
, 1986
THE PHARMACOLOGY OF NEOTAL RESUSCITATION AND CARDIOPULMORY INTENSIVE
, 1986
HEPARIN INHIBITS PROLIFERATION OF FETAL VASCULAR SMOOTH-MUSCLE CELLS IN THE ABSENCE OF PLATELET
, 1986
ENDOTOXIN INDUCED LUNG-CELL INJURY - INVITRO MECHANISMS
, 1986
USE OF SODIUM-NITROPRUSSIDE IN NEOTES - EFFICACY AND SAFETY
, 1985
GROWTH FAILURE SECONDARY TO DEXAMETHASONE IN PRETERM NEOTES
, 1985
GROWTH FAILURE DURING DEXAMETHASONE THERAPY IN PRETERM NEOTES
, 1985
BILIRUBIN BINDING IN THE PLASMA OF NEWBORNS - CRITICAL
, 1984
UPPER AIRWAY-OBSTRUCTION DUE TO LARYNGEAL COCCIDIOIDOMYCOSIS IN A 5-YEAR-OLD CHILD
, 1983
PROTEIN-COMPOSITION OF GLIAL AND NERVE-FIBERS
, 1976